Global Natural Killer Cells Therapeutics Market Research Report 2023

Report ID: 2009657 | Published Date: Jan 2025 | No. of Page: 85 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 NK Cell Therapies
        1.2.3 NK Cell Directed Antibodies
    1.3 Market by Application
        1.3.1 Global Natural Killer Cells Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Cancer
        1.3.3 Gastrointestinal Diseases
        1.3.4 Immunoproliferative Disorders
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Natural Killer Cells Therapeutics Market Perspective (2017-2028)
    2.2 Natural Killer Cells Therapeutics Growth Trends by Region
        2.2.1 Natural Killer Cells Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Natural Killer Cells Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Natural Killer Cells Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Natural Killer Cells Therapeutics Market Dynamics
        2.3.1 Natural Killer Cells Therapeutics Industry Trends
        2.3.2 Natural Killer Cells Therapeutics Market Drivers
        2.3.3 Natural Killer Cells Therapeutics Market Challenges
        2.3.4 Natural Killer Cells Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Natural Killer Cells Therapeutics Players by Revenue
        3.1.1 Global Top Natural Killer Cells Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Natural Killer Cells Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Natural Killer Cells Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Natural Killer Cells Therapeutics Revenue
    3.4 Global Natural Killer Cells Therapeutics Market Concentration Ratio
        3.4.1 Global Natural Killer Cells Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Natural Killer Cells Therapeutics Revenue in 2021
    3.5 Natural Killer Cells Therapeutics Key Players Head office and Area Served
    3.6 Key Players Natural Killer Cells Therapeutics Product Solution and Service
    3.7 Date of Enter into Natural Killer Cells Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Natural Killer Cells Therapeutics Breakdown Data by Type
    4.1 Global Natural Killer Cells Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Natural Killer Cells Therapeutics Forecasted Market Size by Type (2023-2028)
5 Natural Killer Cells Therapeutics Breakdown Data by Application
    5.1 Global Natural Killer Cells Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Natural Killer Cells Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Natural Killer Cells Therapeutics Market Size (2017-2028)
    6.2 North America Natural Killer Cells Therapeutics Market Size by Country (2017-2022)
    6.3 North America Natural Killer Cells Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Natural Killer Cells Therapeutics Market Size (2017-2028)
    7.2 Europe Natural Killer Cells Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Natural Killer Cells Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Natural Killer Cells Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Natural Killer Cells Therapeutics Market Size (2017-2028)
    9.2 Latin America Natural Killer Cells Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Natural Killer Cells Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Natural Killer Cells Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Affimed
        11.1.1 Affimed Company Detail
        11.1.2 Affimed Business Overview
        11.1.3 Affimed Natural Killer Cells Therapeutics Introduction
        11.1.4 Affimed Revenue in Natural Killer Cells Therapeutics Business (2017-2022)
        11.1.5 Affimed Recent Development
    11.2 Celgene
        11.2.1 Celgene Company Detail
        11.2.2 Celgene Business Overview
        11.2.3 Celgene Natural Killer Cells Therapeutics Introduction
        11.2.4 Celgene Revenue in Natural Killer Cells Therapeutics Business (2017-2022)
        11.2.5 Celgene Recent Development
    11.3 Fate Therapeutics
        11.3.1 Fate Therapeutics Company Detail
        11.3.2 Fate Therapeutics Business Overview
        11.3.3 Fate Therapeutics Natural Killer Cells Therapeutics Introduction
        11.3.4 Fate Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2017-2022)
        11.3.5 Fate Therapeutics Recent Development
    11.4 Fortress Biotech
        11.4.1 Fortress Biotech Company Detail
        11.4.2 Fortress Biotech Business Overview
        11.4.3 Fortress Biotech Natural Killer Cells Therapeutics Introduction
        11.4.4 Fortress Biotech Revenue in Natural Killer Cells Therapeutics Business (2017-2022)
        11.4.5 Fortress Biotech Recent Development
    11.5 Glycostem Therapeutics
        11.5.1 Glycostem Therapeutics Company Detail
        11.5.2 Glycostem Therapeutics Business Overview
        11.5.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Introduction
        11.5.4 Glycostem Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2017-2022)
        11.5.5 Glycostem Therapeutics Recent Development
    11.6 Innate Pharma
        11.6.1 Innate Pharma Company Detail
        11.6.2 Innate Pharma Business Overview
        11.6.3 Innate Pharma Natural Killer Cells Therapeutics Introduction
        11.6.4 Innate Pharma Revenue in Natural Killer Cells Therapeutics Business (2017-2022)
        11.6.5 Innate Pharma Recent Development
    11.7 Nantkwest
        11.7.1 Nantkwest Company Detail
        11.7.2 Nantkwest Business Overview
        11.7.3 Nantkwest Natural Killer Cells Therapeutics Introduction
        11.7.4 Nantkwest Revenue in Natural Killer Cells Therapeutics Business (2017-2022)
        11.7.5 Nantkwest Recent Development
    11.8 Nkarta Therapeutics
        11.8.1 Nkarta Therapeutics Company Detail
        11.8.2 Nkarta Therapeutics Business Overview
        11.8.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Introduction
        11.8.4 Nkarta Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2017-2022)
        11.8.5 Nkarta Therapeutics Recent Development
    11.9 NKT Therapeutics
        11.9.1 NKT Therapeutics Company Detail
        11.9.2 NKT Therapeutics Business Overview
        11.9.3 NKT Therapeutics Natural Killer Cells Therapeutics Introduction
        11.9.4 NKT Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2017-2022)
        11.9.5 NKT Therapeutics Recent Development
    11.10 Ziopharm Oncology
        11.10.1 Ziopharm Oncology Company Detail
        11.10.2 Ziopharm Oncology Business Overview
        11.10.3 Ziopharm Oncology Natural Killer Cells Therapeutics Introduction
        11.10.4 Ziopharm Oncology Revenue in Natural Killer Cells Therapeutics Business (2017-2022)
        11.10.5 Ziopharm Oncology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of NK Cell Therapies
    Table 3. Key Players of NK Cell Directed Antibodies
    Table 4. Global Natural Killer Cells Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Natural Killer Cells Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Natural Killer Cells Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Natural Killer Cells Therapeutics Market Share by Region (2017-2022)
    Table 8. Global Natural Killer Cells Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Natural Killer Cells Therapeutics Market Share by Region (2023-2028)
    Table 10. Natural Killer Cells Therapeutics Market Trends
    Table 11. Natural Killer Cells Therapeutics Market Drivers
    Table 12. Natural Killer Cells Therapeutics Market Challenges
    Table 13. Natural Killer Cells Therapeutics Market Restraints
    Table 14. Global Natural Killer Cells Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Natural Killer Cells Therapeutics Market Share by Players (2017-2022)
    Table 16. Global Top Natural Killer Cells Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cells Therapeutics as of 2021)
    Table 17. Ranking of Global Top Natural Killer Cells Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Natural Killer Cells Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Natural Killer Cells Therapeutics Product Solution and Service
    Table 21. Date of Enter into Natural Killer Cells Therapeutics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Natural Killer Cells Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Natural Killer Cells Therapeutics Revenue Market Share by Type (2017-2022)
    Table 25. Global Natural Killer Cells Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Natural Killer Cells Therapeutics Revenue Market Share by Type (2023-2028)
    Table 27. Global Natural Killer Cells Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Natural Killer Cells Therapeutics Revenue Market Share by Application (2017-2022)
    Table 29. Global Natural Killer Cells Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Natural Killer Cells Therapeutics Revenue Market Share by Application (2023-2028)
    Table 31. North America Natural Killer Cells Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Natural Killer Cells Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Natural Killer Cells Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Natural Killer Cells Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Natural Killer Cells Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Natural Killer Cells Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Affimed Company Detail
    Table 42. Affimed Business Overview
    Table 43. Affimed Natural Killer Cells Therapeutics Product
    Table 44. Affimed Revenue in Natural Killer Cells Therapeutics Business (2017-2022) & (US$ Million)
    Table 45. Affimed Recent Development
    Table 46. Celgene Company Detail
    Table 47. Celgene Business Overview
    Table 48. Celgene Natural Killer Cells Therapeutics Product
    Table 49. Celgene Revenue in Natural Killer Cells Therapeutics Business (2017-2022) & (US$ Million)
    Table 50. Celgene Recent Development
    Table 51. Fate Therapeutics Company Detail
    Table 52. Fate Therapeutics Business Overview
    Table 53. Fate Therapeutics Natural Killer Cells Therapeutics Product
    Table 54. Fate Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2017-2022) & (US$ Million)
    Table 55. Fate Therapeutics Recent Development
    Table 56. Fortress Biotech Company Detail
    Table 57. Fortress Biotech Business Overview
    Table 58. Fortress Biotech Natural Killer Cells Therapeutics Product
    Table 59. Fortress Biotech Revenue in Natural Killer Cells Therapeutics Business (2017-2022) & (US$ Million)
    Table 60. Fortress Biotech Recent Development
    Table 61. Glycostem Therapeutics Company Detail
    Table 62. Glycostem Therapeutics Business Overview
    Table 63. Glycostem Therapeutics Natural Killer Cells Therapeutics Product
    Table 64. Glycostem Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2017-2022) & (US$ Million)
    Table 65. Glycostem Therapeutics Recent Development
    Table 66. Innate Pharma Company Detail
    Table 67. Innate Pharma Business Overview
    Table 68. Innate Pharma Natural Killer Cells Therapeutics Product
    Table 69. Innate Pharma Revenue in Natural Killer Cells Therapeutics Business (2017-2022) & (US$ Million)
    Table 70. Innate Pharma Recent Development
    Table 71. Nantkwest Company Detail
    Table 72. Nantkwest Business Overview
    Table 73. Nantkwest Natural Killer Cells Therapeutics Product
    Table 74. Nantkwest Revenue in Natural Killer Cells Therapeutics Business (2017-2022) & (US$ Million)
    Table 75. Nantkwest Recent Development
    Table 76. Nkarta Therapeutics Company Detail
    Table 77. Nkarta Therapeutics Business Overview
    Table 78. Nkarta Therapeutics Natural Killer Cells Therapeutics Product
    Table 79. Nkarta Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2017-2022) & (US$ Million)
    Table 80. Nkarta Therapeutics Recent Development
    Table 81. NKT Therapeutics Company Detail
    Table 82. NKT Therapeutics Business Overview
    Table 83. NKT Therapeutics Natural Killer Cells Therapeutics Product
    Table 84. NKT Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2017-2022) & (US$ Million)
    Table 85. NKT Therapeutics Recent Development
    Table 86. Ziopharm Oncology Company Detail
    Table 87. Ziopharm Oncology Business Overview
    Table 88. Ziopharm Oncology Natural Killer Cells Therapeutics Product
    Table 89. Ziopharm Oncology Revenue in Natural Killer Cells Therapeutics Business (2017-2022) & (US$ Million)
    Table 90. Ziopharm Oncology Recent Development
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Natural Killer Cells Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. NK Cell Therapies Features
    Figure 3. NK Cell Directed Antibodies Features
    Figure 4. Global Natural Killer Cells Therapeutics Market Share by Application in 2021 & 2028
    Figure 5. Cancer Case Studies
    Figure 6. Gastrointestinal Diseases Case Studies
    Figure 7. Immunoproliferative Disorders Case Studies
    Figure 8. Others Case Studies
    Figure 9. Natural Killer Cells Therapeutics Report Years Considered
    Figure 10. Global Natural Killer Cells Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Natural Killer Cells Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Natural Killer Cells Therapeutics Market Share by Region: 2021 VS 2028
    Figure 13. Global Natural Killer Cells Therapeutics Market Share by Players in 2021
    Figure 14. Global Top Natural Killer Cells Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cells Therapeutics as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Natural Killer Cells Therapeutics Revenue in 2021
    Figure 16. North America Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Natural Killer Cells Therapeutics Market Share by Country (2017-2028)
    Figure 18. United States Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Natural Killer Cells Therapeutics Market Share by Country (2017-2028)
    Figure 22. Germany Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Natural Killer Cells Therapeutics Market Share by Region (2017-2028)
    Figure 30. China Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Natural Killer Cells Therapeutics Market Share by Country (2017-2028)
    Figure 38. Mexico Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Natural Killer Cells Therapeutics Market Share by Country (2017-2028)
    Figure 42. Turkey Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Affimed Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2017-2022)
    Figure 45. Celgene Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2017-2022)
    Figure 46. Fate Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2017-2022)
    Figure 47. Fortress Biotech Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2017-2022)
    Figure 48. Glycostem Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2017-2022)
    Figure 49. Innate Pharma Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2017-2022)
    Figure 50. Nantkwest Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2017-2022)
    Figure 51. Nkarta Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2017-2022)
    Figure 52. NKT Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2017-2022)
    Figure 53. Ziopharm Oncology Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Affimed
Celgene
Fate Therapeutics
Fortress Biotech
Glycostem Therapeutics
Innate Pharma
Nantkwest
Nkarta Therapeutics
NKT Therapeutics
Ziopharm Oncology
Frequently Asked Questions
Natural Killer Cells Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Natural Killer Cells Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Natural Killer Cells Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports